{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:39:40Z","timestamp":1783615180148,"version":"3.55.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T00:00:00Z","timestamp":1229904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T00:00:00Z","timestamp":1229904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/bmt.2008.394","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T15:02:34Z","timestamp":1229958154000},"page":"813-816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia"],"prefix":"10.1038","volume":"43","author":[{"given":"H C E","family":"Buyck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Junagade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,22]]},"reference":[{"key":"BFbmt2008394_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.bbmt.2004.09.001","volume":"10","author":"V Gupta","year":"2004","unstructured":"Gupta V, Ball SE, Yi QL, Sage D, McCann SR, Lawler M et al. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Biol Blood Marrow Transplant 2004; 10: 867\u2013876.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008394_CR2","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1182\/blood-2006-09-045625","volume":"109","author":"P Scheinberg","year":"2007","unstructured":"Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, Sloand EM et al. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 2007; 109: 3219\u20133224.","journal-title":"Blood"},{"key":"BFbmt2008394_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1046\/j.1365-2141.1998.00578.x","volume":"100","author":"A Tichelli","year":"1998","unstructured":"Tichelli A, Passweg J, Nissen C, Bargetzi M, Hoffmann T, Wodnar-Filipowicz A et al. Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia. Br J Haematol 1998; 100: 393\u2013400.","journal-title":"Br J Haematol"},{"key":"BFbmt2008394_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1182\/blood.V102.3.839","volume":"102","author":"S Chakrabarti","year":"2003","unstructured":"Chakrabarti S, Milligan DW, Pillay D, Mackinnon S, Holder K, Kaur N et al. Reconstitution of the Epstein\u2013Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. Blood 2003; 102: 839\u2013842.","journal-title":"Blood"},{"key":"BFbmt2008394_CR5","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1182\/blood-2006-03-011791","volume":"108","author":"CG Brunstein","year":"2006","unstructured":"Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA et al. Marked increased risk of Epstein\u2013Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874\u20132880.","journal-title":"Blood"},{"key":"BFbmt2008394_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/sj.bmt.1703806","volume":"31","author":"AW Loren","year":"2003","unstructured":"Loren AW, Porter DL, Stadtmauer EA, Tsai DE . Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 2003; 31: 145\u2013155.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008394_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1365-2141.2004.05287.x","volume":"128","author":"S Cesaro","year":"2005","unstructured":"Cesaro S, Murrone A, Mengoli C, Pillon M, Biasolo MA, Calore E et al. The real-time polymerase chain reaction-guided modulation of immunosuppression enables the pre-emptive management of Epstein\u2013Barr virus reactivation after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2005; 128: 224\u2013233.","journal-title":"Br J Haematol"},{"key":"BFbmt2008394_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/00365540600978906","volume":"39","author":"A Kinch","year":"2007","unstructured":"Kinch A, Oberg G, Arvidson J, Falk KI, Linde A, Pauksens K . Post-transplant lymphoproliferative disease and other Epstein\u2013Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction. Scand J Infect Dis 2007; 39: 235\u2013244.","journal-title":"Scand J Infect Dis"},{"key":"BFbmt2008394_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/10428190601059837","volume":"48","author":"JM Cohen","year":"2007","unstructured":"Cohen JM, Cooper N, Chakrabarti S, Thomson K, Samarasinghe S, Cubitt D et al. EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning. Leuk Lymphoma 2007; 48: 256\u2013269.","journal-title":"Leuk Lymphoma"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008394","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:12:57Z","timestamp":1648033977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,22]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFbmt2008394"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.394","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,22]]},"assertion":[{"value":"16 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}